Skip to main content

Alan W. Katz, M.D., M.P.H.

Contact Information

Phone Numbers

Appointment: (585) 275-2171

Office: (585) 275-3913

Fax: (585) 275-1531

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentNot Accepting New Patients

Patient Care Settings

Cancer, Radiation Oncology


I was drawn to gastrointestinal oncology because it is a challenging field, which includes some of the most lethal cancers. Radiation therapy plays an important role in the management of these diverse malignancies, including its use prior to surgery, as definitive treatment with chemotherapy and for palliation of local or metastatic disease. I also have expertise in stereotactic body radiation therapy for the treatment of primary and metastatic gastrointestinal malignancies.

My philosophy of patient care is based on a personalized approach, providing each patient with comprehensive information regarding his or her diagnosis, treatment options and prognosis. It is a privilege to be entrusted with a patient's care – and I will always do my best to treat my patients with integrity, compassion and respect.

Conditions I Treat

- Esophageal cancer
- Pancreatic cancer
- Liver cancer
- Rectal cancer
- Anal cancer
- Other gastrointestinal malignancies



MD | Sackler School of Medicine (Tel Aviv University)

Post-doctoral Training & Residency

07/01/1991 - 06/30/1992
Fellowship in Radiation Oncology at University of Rochester School of Medicine GME

09/01/1986 - 12/01/1993
Residency at Chaim Sheba Medical Center (Israel)

08/30/1985 - 07/30/1986
Internship at Assaf Nasofeh Medical Center

VIEW ALL expand_more


2011 - 2014
Physician's Recognition Award
Sponsor: American Medical Association

Casarett Award
Sponsor: Department of Radiation Oncology, University of Rochester
Location: Rochester, NY


Journal Articles

Kachnic LA; Winter KA; Myerson RJ; Goodyear MD; Abitbol AA; Streeter OE; Augspurger ME; Schefter TE; Katz AW; Fisher BJ; Henke LE; Narayan S; Crane CH. "Long-term outcomes of NRG Oncology/RTOG 0529: a Phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in anal canal cancer". Int J Radiat Oncol Biol Phys. 2022; 112(1): 146-157.

Mills BN; Qiu H; Drage MG; Chen C; Mathew JS; Garrett-Larsen J; Ye J; Uccello TP; Murphy JD; Belt BA; Lord EM; Katz AW; Linehan DC; Gerber SA. "Modulation of the human pancreatic ductal adenocarcinoma immune microenvironment by stereotactic body radiotherapy". Clin Cancer Res. 2022; 28(1): 150-162.

Safran HP; Winter K; Ilson DH; Wigle D; DiPetrillo T; Haddock MG; Hong TS; Leichman LP; Rajdev L; Resnick M; Kachnic LA; Seaward S; Mamon H; Diaz Pardo DA; Anderson CM; Shen X; Sharma AK; Katz AW; Salo J; Leonard KL; Moughan J; Crane CH. "Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial". Lancet Oncol. 2022; 23(2): 259-269.

Books & Chapters

Chapter Title: The Testes
Book Title: ALERT: Adverse Late Effects of Cancer Treatment
Author List: Ginsberg JP; Katz AW
Edited By: Rubin P, Constine LS, Marks LB
Published By: Springer 2013 in New York

Chapter Title: Liver metastasis
Book Title: Stereotactic Body Radiation Therapy
Author List: Stinauer M; Lanciano R; Schefter TE; Kavanagh B; Carlson JA; Katz AW
Edited By: Lo SS; Teh BS; Lu JJ; Schefter TE
Published By: Springer 2012 in Heidelberg

Chapter Title: KV planar image-guided SBRT using the Novalis system in an ovarian cancer patient with liver metastases
Book Title: Image Guided Radiation Therapy: A Clinical Perspective
Author List: Katz AW; Cheruvu P; Schell MC; Phillip A; Milano MT
Edited By: Mundt AJ; Roeske JC
Published By: People's Medical Publishing House-USA 2011 in Shelton, CT